Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

References for PMC Articles for PubMed (Select 18794355)

1.

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T.

EMBO Rep. 2008 Jun;9(6):582-9. doi: 10.1038/embor.2008.74. Epub 2008 May 16.

2.

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.

Korpal M, Lee ES, Hu G, Kang Y.

J Biol Chem. 2008 May 30;283(22):14910-4. doi: 10.1074/jbc.C800074200. Epub 2008 Apr 14.

3.

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

Park SM, Gaur AB, Lengyel E, Peter ME.

Genes Dev. 2008 Apr 1;22(7):894-907. doi: 10.1101/gad.1640608. Erratum in: Genes Dev. 2009 Jun 1;23(11):1378.

4.

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ.

Nat Cell Biol. 2008 May;10(5):593-601. doi: 10.1038/ncb1722. Epub 2008 Mar 30.

PMID:
18376396
5.

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.

Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ.

Cancer Res. 2008 Jan 15;68(2):425-33. doi: 10.1158/0008-5472.CAN-07-2488. Erratum in: Cancer Res. 2008 Mar 1;68(5):1609.

6.

A viral microRNA functions as an orthologue of cellular miR-155.

Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR.

Nature. 2007 Dec 13;450(7172):1096-9.

7.

microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.

Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M.

Immunity. 2007 Dec;27(6):847-59. Epub 2007 Dec 6.

8.

B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element.

Yin Q, Wang X, McBride J, Fewell C, Flemington E.

J Biol Chem. 2008 Feb 1;283(5):2654-62. Epub 2007 Nov 28.

9.

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, P├ębusque MJ, Dusetti NJ.

Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16170-5. Epub 2007 Oct 2.

10.

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Ma L, Teruya-Feldstein J, Weinberg RA.

Nature. 2007 Oct 11;449(7163):682-8. Epub 2007 Sep 26. Erratum in: Nature. 2008 Sep 11;455(7210):256.

PMID:
17898713
11.

The role of site accessibility in microRNA target recognition.

Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E.

Nat Genet. 2007 Oct;39(10):1278-84. Epub 2007 Sep 23.

PMID:
17893677
12.

Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155.

Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R.

J Virol. 2007 Dec;81(23):12836-45. Epub 2007 Sep 19.

13.

Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity.

Zavadil J, Narasimhan M, Blumenberg M, Schneider RJ.

Cells Tissues Organs. 2007;185(1-3):157-61. Review.

PMID:
17587821
14.

MicroRNAs in human cancer: from research to therapy.

Negrini M, Ferracin M, Sabbioni S, Croce CM.

J Cell Sci. 2007 Jun 1;120(Pt 11):1833-40.

15.

Requirement of bic/microRNA-155 for normal immune function.

Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A.

Science. 2007 Apr 27;316(5824):608-11.

16.

Regulation of the germinal center response by microRNA-155.

Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K.

Science. 2007 Apr 27;316(5824):604-8.

17.

Potent effect of target structure on microRNA function.

Long D, Lee R, Williams P, Chan CY, Ambros V, Ding Y.

Nat Struct Mol Biol. 2007 Apr;14(4):287-94. Epub 2007 Apr 1.

PMID:
17401373
18.

MicroRNA-155 is induced during the macrophage inflammatory response.

O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D.

Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9. Epub 2007 Jan 22.

19.

A microRNA signature of hypoxia.

Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M.

Mol Cell Biol. 2007 Mar;27(5):1859-67. Epub 2006 Dec 28.

20.

Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.

Kluiver J, van den Berg A, de Jong D, Blokzijl T, Harms G, Bouwman E, Jacobs S, Poppema S, Kroesen BJ.

Oncogene. 2007 May 31;26(26):3769-76. Epub 2006 Dec 18.

PMID:
17173072
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk